Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Karen Visser

EULAR Points to Consider for the Diagnosis and Management of Rheumatic Immune-Related Adverse Events Due to Cancer Immunotherapy With Checkpoint Inhibitors

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2020English

Living Renal Donors: Optimizing the Imaging Strategy—Decision- And Cost-Effectiveness Analysis

Radiology
Nuclear MedicineRadiologyImaging
2003English

Related publications

Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Treatment- And Immune-Related Adverse Events of Immune Checkpoint Inhibitors in Advanced Lung Cancer

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

5) Management of Neurological Adverse Events Associated With Immune Checkpoint Inhibitors

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Management of Immune Checkpoint Inhibitor‐related Dermatologic Adverse Events

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Immune-Related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors

Anticancer Research
MedicineCancer ResearchOncology
2020English

Treatment-Related Adverse Events and Response Rate to Immune Checkpoint Inhibition

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

4) Immune-Related Adverse Events in Endocrine Organs Induced by Immune Checkpoint Inhibitors

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Concurrent Therapy With Immune Checkpoint Inhibitors and TNFα Blockade in Patients With Gastrointestinal Immune-Related Adverse Events

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Safety of Checkpoint Inhibitors for Cancer Treatment: Strategies for Patient Monitoring and Management of Immune-Mediated Adverse Events

ImmunoTargets and Therapy
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy